Nghiên cứu mới về vaccine COVID-19 từ ngày 21/01 đến ngày 28/01/2022
Cập nhật vào: Thứ sáu - 28/01/2022 00:54 Cỡ chữ
Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về vaccine COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 21/1 đến ngày 28/1/2022. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.
1. Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
Clinica Chimica Acta, 27 November 2021, Volume 524 (Cover date: 1 January 2022), Pages 11-17
Giacomo Malipiero, Pierlanfranco D'Agaro, Danilo Villalta
2. Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh
Journal of Infection and Public Health, 7 December 2021, Volume 15, Issue 2 (Cover date: February 2022), Pages 156-163
Hassan M. Al-Emran, Md. Shazid Hasan, M. Anwar Hossain
3. Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2
Journal of Virological Methods, 13 December 2021, Volume 300 (Cover date: February 2022), Article 114422
Gabriela Bastos Cabral, Cintia Mayumi Ahagon, Luís Fernando de Macedo Brígido
4. Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches
Computers in Biology and Medicine, 25 December 2021, Volume 141 (Cover date: February 2022), Article 105170
Abdullah Shah, Saira Rehmat, Dong-Qing Wei
5. Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants
Genes & Diseases, 29 June 2021, Volume 9, Issue 1 (Cover date: January 2022), Pages 216-229
6. Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients
Diagnostic Microbiology and Infectious Disease, 2 October 2021, Volume 102, Issue 2 (Cover date: February 2022), Article 115566
Mai-Lei Woo Kinshella, Peter Tilley, David M. Goldfarb
7. Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2
Arabian Journal of Chemistry, 1 December 2021, Volume 15, Issue 2 (Cover date: February 2022), Article 103600
Gobindo Kumar Paul, Shafi Mahmud, Md. Abu Saleh
8. Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
Biosensors and Bioelectronics, 15 December 2021, Volume 199 (Cover date: 1 March 2022), Article 113883
Xuejun Duan, Yijun Shi, Guojun Zhang
9. Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
Journal of Virological Methods, 10 December 2021, Volume 301 (Cover date: March 2022), Article 114424
10. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
EBioMedicine, 17 December 2021, Volume 75 (Cover date: January 2022), Article 103761
Rüdiger Groß, Michelle Zanoni, Janis A. Müller
11. Isolation of SARS-CoV-2 B.22.214.171.124 (P2) variant and pathogenicity comparison with D614G variant in hamster model
Journal of Infection and Public Health, 21 December 2021, Volume 15, Issue 2 (Cover date: February 2022), Pages 164-171
Pragya Yadav, Sreelekshmy Mohandas, Balram Bhargava
12. Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein
Molecular Immunology, 10 December 2021, Volume 141 (Cover date: January 2022), Pages 287-296
Reda Salem, Alaa A. El-Kholy, Mai Hussein
13. Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
Journal of Molecular Structure, 19 November 2021, Volume 1250, Part 3 (Cover date: 15 February 2022), Article 131920
Reaz Uddin, Khurshid Jalal, Zaheer ul-Haq
14. Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health?
Science of The Total Environment, 21 December 2021, Volume 813 (Cover date: 20 March 2022), Article 152345
Bianca H. Ventura Fernandes, Natália Martins Feitosa, Ives Charlie-Silva
15. A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
Journal of Clinical Virology, 1 December 2021, Volume 146 (Cover date: January 2022), Article 105050
Fang Fang Li, Aaron Liu, Agatha N. Jassem
1. Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic
Charlotte G. Mortz, Henrik F. Kjaer, Trine H. Rasmussen, Helene M. Rasmussen, Lene Heise Garvey, Carsten Bindslev-Jensen
Clinical and Translational AllergyVolume 12, Issue 1
First published: 08 January 2022
2. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients
Osnat Itzhaki Ben Zadok, Aviv A. Shaul, Binyamin Ben-Avraham, Vicky Yaari, Haim Ben Zvi, Noa Eliakim-Raz, Dafna Yahav, Galia Abed, Miriam Abuhazira, Yaron D. Barac, Israel Mats, Tzippy Shochat, Dan Aravot, Ran Kornowski, Tuvia Ben-Gal
ESC Heart FailureEarly View
First published: 03 January 2022
3. Collective learning and COVID-19 mitigation in Ghana
Alex Osei-Kojo, Paul Lawer Kenney, Clement Mensah Damoah, Albert Ahenkan
Review of Policy ResearchEarly View
First published: 11 January 2022
4. COVID-19 vaccination is protective of clinical disease in solid organ transplant recipients
Saima Aslam, Jinyuan Liu, Rachel Sigler, Rehan R. Syed, Xin M. Tu, Susan J. Little, Victor De Gruttola
Transplant Infectious DiseaseAccepted Articles
First published: 05 January 2022
5. Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID-19 pandemic
Sema Koç Yıldırım MD, Neslihan Demirel Öğüt MD, Ece Erbağcı MD
Journal of Cosmetic DermatologyEarly View
First published: 04 January 2022
6. Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate
Stephen C De Rosa, Kristen W Cohen, Matthew Bonaparte, Bo Fu, Sanjay Garg, Catherine Gerard, Paul A Goepfert, Ying Huang, Daniel Larocque, M. Juliana McElrath, Daryl Morris, Robbert Van der Most, Guy de Bruyn, Anke Pagnon
Clinical & Translational ImmunologyVolume 11, Issue 1
First published: 11 January 2022
7. COVID-opt-aiNet: A clinical decision support system for COVID-19 detection
Summrina Kanwal, Faiza Khan, Sultan Alamri, Kia Dashtipur, Mandar Gogate
International Journal of Imaging Systems and TechnologyEarly View
First published: 03 January 2022
8. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients
Ana Luísa Correia, Rita Leal, Ana Carolina Pimenta, Mariana Fernandes, Maria Guedes Marques, Luís Rodrigues, Lídia Santos, Catarina Romãozinho, Helena Sá, Jorge Pratas, Lucília Araújo, Arnaldo Figueiredo, Rui Alves
Clinical TransplantationAccepted Articles
First published: 08 January 2022
1. IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID-19 vaccines.
Kelso JM.Clin Exp Allergy. 2022 Jan;52(1):10-11. doi: 10.1111/cea.13995. Epub 2021 Sep 21.
2. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH.J Cutan Pathol. 2022 Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8.
3. [18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.
Skawran S, Gennari AG, Dittli M, Treyer V, Muehlematter UJ, Maurer A, Burger IA, Mader C, Messerli O, Grünig H, Gebhard C, Huellner MW, Curioni-Fontecedro A, Berger C, Messerli M.Eur Radiol. 2022 Jan;32(1):508-516. doi: 10.1007/s00330-021-08122-2. Epub 2021 Jun 22.
4. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
Ismail II, Salama S.J Neuroimmunol. 2022 Jan 15; 362:577765. doi: 10.1016/j.jneuroim.2021.577765. Epub 2021 Nov 9.
5. Vaccine-induced immune thrombotic thrombocytopenia.
Klok FA, Pai M, Huisman MV, Makris M. Lancet Haematol. 2022 Jan; 9(1): e73-e80. doi: 10.1016/S2352-3026(21)00306-9. Epub 2021 Nov 11.
6. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Briggs FBS, Mateen FJ, Schmidt H, Currie KM, Siefers HM, Crouthamel S, Bebo BF, Fiol J, Racke MK, O'Connor KC, Kolaczkowski LG, Klein P, Loud S, McBurney RN.Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1104. doi: 10.1212/NXI.0000000000001104. Print 2022 Jan.
7. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.
Mehta H, Handa S, Malhotra P, Patial M, Gupta S, Mukherjee A, Chatterjee D, Takkar A, Mahajan R.J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e16-e18. doi: 10.1111/jdv.17678. Epub 2021 Oct 5.
8. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
Guan CY, Tsai SH, Fan JS, Lin YK, Kao CC.Am J Emerg Med. 2022 Jan;51:427.e3-427.e4. doi: 10.1016/j.ajem.2021.07.011. Epub 2021 Jul 8.
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022
Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022
Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022
Nguồn: Cục Thông tin KH&CN Quốc gia, 28/1/2022